Related Experiment Video
Updated: Jul 5, 2026

10:33
A Caenorhabditis elegans Model System for Amylopathy Study
Published on: May 17, 2013
Caenorhabditis elegans as a model for lysosomal storage disorders
Gert de Voer1, Dorien Peters, Peter E M Taschner
1Department of Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Biochimica Et Biophysica Acta
|May 27, 2008
Summary
The nematode Caenorhabditis elegans offers a powerful model for studying human lysosomal storage disorders. Researchers compiled worm gene homologues and analyzed mutant phenotypes, revealing diverse disease presentations and aiding future genetic research.
Area of Science:
- Genetics
- Molecular Biology
- Developmental Biology
Background:
- Lysosomal storage disorders (LSDs) are a group of inherited metabolic diseases.
- The nematode Caenorhabditis elegans serves as a valuable model organism for studying human diseases due to its genetic tractability and conserved biological pathways.
- Understanding the genetic basis and phenotypic consequences of LSDs is crucial for developing therapeutic strategies.
Purpose of the Study:
- To compile a comprehensive list of Caenorhabditis elegans (C. elegans) homologues for human genes implicated in lysosomal storage disorders and general lysosomal function.
- To summarize and discuss the known phenotypes of C. elegans mutants corresponding to these genes.
- To provide a resource for researchers studying lysosomal function and designing genetic screens in C. elegans.
Main Methods:
- Systematic compilation of C. elegans gene homologues for 58 human LSD genes and 105 human lysosomal function genes.
- Literature review and summarization of phenotypic data for 147 C. elegans mutants with disrupted or knocked-down target genes.
- Analysis of the phenotypic spectrum observed in C. elegans models of LSDs.
Main Results:
- A significant number of human LSD and lysosomal function genes have at least one identifiable homologue in C. elegans.
- The phenotypic spectrum of C. elegans LSD models is broad, ranging from lethality to subtle or unobservable phenotypes.
- Existing genetic screens have successfully identified genes involved in lysosomal biogenesis and function (e.g., cup and glo mutants).
Conclusions:
- C. elegans is a powerful and accessible model system for investigating the genetic and phenotypic aspects of human lysosomal storage disorders.
- The compiled data and phenotypic overview can guide the characterization of new knock-out models and the design of targeted genetic screens.
- While screens for severe phenotypes are feasible, identifying genes associated with subtle lysosomal defects in C. elegans may present challenges.

